What are the key advantages of choosing GMP-grade K562 feeder cells over developing an in-house system?

In the development of NK cells, CAR-NK cells, and TILs, building an in-house feeder cell system typically involves multiple complex stages, including cell construction, genetic engineering, process optimization, quality system establishment, and regulatory documentation preparation. This approach is time-consuming and carries high uncertainty.

In contrast, the key advantages of using Hillgene’s GMP-grade K562 feeder cells are:

· Standardized starting point: Based on a stable cell platform with an established GMP production system, reducing the uncertainty of developing from scratch

· Comprehensive CMC support: Covers cell sourcing, process development, quality control, and stability studies, ready to support IND submissions

· Regulatory readiness: Supported by DMF filing and ICH-compliant methodologies, lowering submission risk and regulatory communication burden

· Scalability: Suitable for NK/CAR-NK cell production from laboratory scale to industrial-scale manufacturing

· Time and cost efficiency: Significantly reduces process development and validation timelines, accelerating translation from research to clinical application

Therefore, Hillgene's GMP-grade K562 feeder cells are not only a functional tool but also a standardized CMC and manufacturing solution platform designed for the industrialization of cell therapy products.

See how our solution can support your project: Genetically Modified K562 Feeder Cell - Hillgene Biopharma Co., Ltd.